Cuu Long Pharmaceutical JSC (HOSE:DCL)

Market Cap	1.86T
Revenue (ttm)	1.37T
Net Income (ttm)	56.44B
Shares Out	73.04M
EPS (ttm)	772.15
PE Ratio	32.90
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	576,571
Average Volume	583,135
Open	25,500
Previous Close	26,300
Day's Range	25,400 - 25,900
52-Week Range	19,000 - 32,000
Beta	0.50
RSI	61.68
Earnings Date	Apr 24, 2025

About HOSE:DCL

Cuu Long Pharmaceutical Joint Stock Company produces drugs, chemicals, and medicine primarily in Vietnam. The company offers antiallergy, pain reliever and fever reducer, antibiotic, anti-inflammatory, antiviral, cardiovascular, corticosteroid, cough, dermatology, digestive, musculoskeletal, and vitamin and mineral medicines, as well as capsules and medical equipment. It sells its products to hospitals, pharmacies, and drugstores. Additionally, the company is involved in the trading pharmaceuticals and medical equipment, and producing medicine,...

• Industry: Pharmaceutical Preparations
• Founded: 1976
• Employees: 885
• Stock Exchange: Ho Chi Minh Stock Exchange
• Ticker Symbol: DCL

Financial Performance

In 2024, HOSE:DCL's revenue was 1.31 trillion, an increase of 14.24% compared to the previous year's 1.14 trillion. Earnings were 53.57 billion, a decrease of -10.29%.